Acrivastine/pseudoephedrine (Semprex-D) for seasonal allergic rhinitis.
D004338:Drug Combinations; D004809:Ephedrine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006634:Histamine H1 Antagonists / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*; D014311:Triprolidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use
D004338:Drug Combinations; D006634:Histamine H1 Antagonists; D014311:Triprolidine; C043648:acrivastine; D004809:Ephedrine